Leukemia & Lymphoma, Volume 56, Issue 11 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 56, Issue 11 (2015)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Volume 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Vol 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentaries

Article Commentary
MYC in diffuse large B-cell lymphoma: always the bad guy?
Marie José Kersten & Jeroen E. J. Guikema
Pages: 3003-3004
Published online: 18 Jun 2015
CitationforMYC in diffuse large B-cell lymphoma: always the bad guy? | Full Text | References | PDF (189.2 KB) | Supplemental
  • 234 Views
  • 1 CrossRef citations
  • 0Altmetric
Article Commentary
Is it time to use minimal residual disease to stratify post-remission treatment for acute myeloid leukemia?
Hongtao Liu & Wendy Stock
Pages: 3005-3007
Published online: 19 Jun 2015
First Page PreviewforIs it time to use minimal residual disease to stratify post-remission treatment for acute myeloid leukemia? | Full Text | References | PDF (191.2 KB) | Supplemental
  • 175 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
A new piece to the stereotypy “puzzle” in chronic lymphocytic leukemia
Richard Rosenquist
Pages: 3008-3009
Published online: 20 Nov 2015
CitationforA new piece to the stereotypy “puzzle” in chronic lymphocytic leukemia | Full Text | References | PDF (151.6 KB) | Supplemental
  • 77 Views
  • 0 CrossRef citations
  • 0Altmetric
Article Commentary
Synergism between arsenic trioxide and aclacinomycin in acute myeloid leukemia
Dennis J. Goussetis & Leonidas C. Platanias
Pages: 3010-3011
Published online: 18 Jun 2015
CitationforSynergism between arsenic trioxide and aclacinomycin in acute myeloid leukemia | Full Text | References | PDF (183.5 KB) | Supplemental
  • 76 Views
  • 0 CrossRef citations
  • 0Altmetric

Reviews

The risk of secondary primary malignancies after therapy for multiple myeloma
Nuchanan Areethamsirikul & Donna E. Reece
Pages: 3012-3021
Published online: 20 Nov 2015
AbstractforThe risk of secondary primary malignancies after therapy for multiple myeloma | Full Text | References | PDF (201.1 KB) | Supplemental
  • 955 Views
  • 12 CrossRef citations
  • 0Altmetric
Molecular pathology of myelodysplastic syndromes: new developments and implications for diagnosis and treatment
Xiaohui Zhang, Jeffrey E. Lancet & Ling Zhang
Pages: 3022-3030
Published online: 26 May 2015
AbstractforMolecular pathology of myelodysplastic syndromes: new developments and implications for diagnosis and treatment | Full Text | References | PDF (247.6 KB) | Supplemental
  • 483 Views
  • 5 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997
David M. Lucas, Amy S. Ruppert, Gerard Lozanski, Gordon W. Dewald, Arletta Lozanski, Rainer Claus, Christoph Plass, Ian W. Flinn, Donna S. Neuberg, Elisabeth M. Paietta, John M. Bennett, Diane F. Jelinek, John G. Gribben, Mohamad A. Hussein, Frederick R. Appelbaum, Richard A. Larson, Dennis F. Moore Jr, Martin S. Tallman, John C. Byrd & Michael R. Grever
Pages: 3031-3037
Published online: 30 Mar 2015
AbstractforCytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997 | Full Text | References | PDF (313.3 KB) | Supplemental
  • 343 Views
  • 8 CrossRef citations
  • 0Altmetric
A modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma
Liang Wang, Zhong-jun Xia, Yue Lu, Qiao-xuan Wang, Shao-qing Niu, Hui-qiang Huang & Yu-jing Zhang
Pages: 3038-3044
Published online: 28 Mar 2015
AbstractforA modified international prognostic index including pretreatment hemoglobin level for early stage extranodal natural killer/T cell lymphoma | Full Text | References | PDF (367.7 KB) | Supplemental
  • 226 Views
  • 7 CrossRef citations
  • 0Altmetric
Methotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal
Yumiko Inui, Hiroshi Matsuoka, Kimikazu Yakushijin, Atsuo Okamura, Takaki Shimada, Shingo Yano, Mai Takeuchi, Mitsuhiro Ito, Tohru Murayama, Katsuya Yamamoto, Tomoo Itoh, Keisuke Aiba & Hironobu Minami
Pages: 3045-3051
Published online: 12 May 2015
AbstractforMethotrexate-associated lymphoproliferative disorders: management by watchful waiting and observation of early lymphocyte recovery after methotrexate withdrawal | Full Text | References | PDF (413.4 KB)
  • 988 Views
  • 65 CrossRef citations
  • 0Altmetric
A subset of CD45+/CD19 − cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma
Sung Min Kim, Seung-Tae Lee, Kyung Ju Ryu, Hee-Jin Kim, Sun-Hee Kim, Young Hye Ko, Won Seog Kim & Seok Jin Kim
Pages: 3052-3057
Published online: 08 Apr 2015
AbstractforA subset of CD45+/CD19 − cells in bone marrow may be associated with clinical outcomes of patients with mantle cell lymphoma | Full Text | References | PDF (329 KB)
  • 546 Views
  • 3 CrossRef citations
  • 0Altmetric
Impact of body mass index on pulmonary complications in patients with non-Hodgkin lymphoma treated with hematopoietic stem cell transplant
Chi Lin, Jeffmin Lin, Mark Stavas, Sicong Li, Kerry J. Canady, Debra J. Romberger & Fausto R. Loberiza Jr
Pages: 3058-3064
Published online: 08 Apr 2015
AbstractforImpact of body mass index on pulmonary complications in patients with non-Hodgkin lymphoma treated with hematopoietic stem cell transplant | Full Text | References | PDF (221.5 KB)
  • 114 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Phase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas
Peter Martin, Richard R. Furman, Sarah Rutherford, Jia Ruan, Scott Ely, June Greenberg, Morton Coleman, Stanley J. Goldsmith & John P. Leonard
Pages: 3065-3070
Published online: 12 May 2015
AbstractforPhase I study of the anti-CD74 monoclonal antibody milatuzumab (hLL1) in patients with previously treated B-cell lymphomas | Full Text | References | PDF (272 KB) | Supplemental
  • 423 Views
  • 17 CrossRef citations
  • 0Altmetric
Carmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas
Ioanna Sakellari, Despoina Mallouri, Ioannis Batsis, Chrysa Apostolou, Varnavas Konstantinou, Eleni-Maria Abela, Vasiliki Douka, Anastasia Marvaki, Kyriakos Karypidis, Michalis Iskas, Panayiotis Baliakas, Panayotis Kaloyannidis, Evangelia Yannaki, Damianos Sotiropoulos, Giorgos Kouvatseas, Christos Smias & Achilles Anagnostopoulos
Pages: 3071-3081
Published online: 07 Apr 2015
AbstractforCarmustine, etoposide, cytarabine and melphalan versus a newly designed intravenous busulfan-based Busulfex, etoposide and melphalan conditioning regimen for autologous hematopoietic cell transplant: a retrospective matched-pair analysis in advanced Hodgkin and non-Hodgkin lymphomas | Full Text | References | PDF (302 KB) | Supplemental
  • 496 Views
  • 14 CrossRef citations
  • 0Altmetric
Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome
Gabriel C. Caponetti, Bhavana J. Dave, Anamarija M. Perry, Lynette M. Smith, Smrati Jain, Paul N. Meyer, Martin Bast, Philip J. Bierman, Robert G. Bociek, Julie M. Vose, James O. Armitage, Patricia Aoun, Kai Fu, Timothy C. Greiner, Wing C. Chan, Warren G. Sanger & Dennis D. Weisenburger
Pages: 3082-3089
Published online: 12 May 2015
AbstractforIsolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome | Full Text | References | PDF (379.3 KB) | Supplemental
  • 474 Views
  • 13 CrossRef citations
  • 0Altmetric
Clinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma
Lionel Kerhuel, Sandy Amorim, Elie Azoulay, Catherine Thiéblemont & Emmanuel Canet
Pages: 3090-3095
Published online: 12 May 2015
AbstractforClinical features of life-threatening complications following autologous stem cell transplantation in patients with lymphoma | Full Text | References | PDF (254.7 KB) | Supplemental
  • 314 Views
  • 7 CrossRef citations
  • 0Altmetric
Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy
Ruben Fernandez-Alvarez, Ana P. Gonzalez-Rodriguez, M. Esther Gonzalez, Arturo Rubio-Castro, Francisco Dominguez-Iglesias, Jackeline Solano, Eva Alonso-Nogues, Carmen Fernandez-Alvarez, Yahya Zanabili, Jose Manuel Alonso, Angel Ramirez Payer, Jose Maria Vicente, Jesus Medina & Juan M. Sancho
Pages: 3096-3102
Published online: 12 May 2015
AbstractforSerum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy | Full Text | References | PDF (334.8 KB) | Supplemental
  • 209 Views
  • 7 CrossRef citations
  • 0Altmetric
Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia
Vladan Rajić, Maruša Debeljak, Katja Goričar & Janez Jazbec
Pages: 3103-3108
Published online: 30 Mar 2015
AbstractforPolymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia | Full Text | References | PDF (266.8 KB) | Supplemental
  • 436 Views
  • 17 CrossRef citations
  • 0Altmetric
Elevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission
Merav Bar, Megan Othus, Hanahlyn M. Park, Vicky Sandhu, Xueyan Chen, Brent L. Wood & Elihu Estey
Pages: 3109-3115
Published online: 12 May 2015
AbstractforElevated lymphocyte count at time of acute myeloid leukemia diagnosis is associated with shorter remission | Full Text | References | PDF (326.4 KB) | Supplemental
  • 332 Views
  • 8 CrossRef citations
  • 0Altmetric
Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy
Ya-Zhen Qin, Lan-Ping Xu, Huan Chen, Qian Jiang, Yu Wang, Hao Jiang, Xiao-Hui Zhang, Wei Han, Yu-Hong Chen, Feng-Rong Wang, Jing-Zhi Wang, Hong-Hu Zhu, Yan-Rong Liu, Bin Jiang, Kai-Yan Liu & Xiao-Jun Huang
Pages: 3116-3123
Published online: 12 May 2015
AbstractforAllogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy | Full Text | References | PDF (510.1 KB) | Supplemental
  • 538 Views
  • 22 CrossRef citations
  • 0Altmetric
A single-center case series of eight patients with the rare plasma cell dyscrasia of acquired Fanconi syndrome secondary to monoclonal gammopathy
Yang Liu, Tienan Zhu, Lingling Xu, Yan Qin & Junling Zhuang
Pages: 3124-3128
Published online: 07 Apr 2015
AbstractforA single-center case series of eight patients with the rare plasma cell dyscrasia of acquired Fanconi syndrome secondary to monoclonal gammopathy | Full Text | References | PDF (258.1 KB) | Supplemental
  • 384 Views
  • 2 CrossRef citations
  • 0Altmetric
Lenalidomide in patients with red blood cell transfusion-dependent myelodysplastic syndrome and del(5q): a single-centre “real-world” experience
Elisa Cerqui, Annamaria Pelizzari, Francesca Schieppati, Erika Borlenghi, Chiara Pagani, Daniela Bellotti, Cinzia Lamorgese, Leonardo Boiocchi, Alessandra Sottini, Luisa Imberti & Giuseppe Rossi
Pages: 3129-3134
Published online: 12 May 2015
AbstractforLenalidomide in patients with red blood cell transfusion-dependent myelodysplastic syndrome and del(5q): a single-centre “real-world” experience | Full Text | References | PDF (287.1 KB) | Supplemental
  • 526 Views
  • 1 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia
Reem Karmali, Melissa L. Larson, Jamile M. Shammo, Sanjib Basu, Kent Christopherson, Jeffrey A. Borgia & Parameswaran Venugopal
Pages: 3135-3142
Published online: 14 May 2015
AbstractforImpact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia | Full Text | References | PDF (455.8 KB) | Supplemental
  • 264 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Economic impact of disease progression following front-line therapy in classical Hodgkin lymphoma
Christopher A. Yasenchak, Wan-Yu Tseng, Mark Yap, Debra Rembert & Debra A. Patt
Pages: 3143-3149
Published online: 18 May 2015
AbstractforEconomic impact of disease progression following front-line therapy in classical Hodgkin lymphoma | Full Text | References | PDF (321.5 KB) | Supplemental
  • 206 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia
Francesco Maura, Giovanna Cutrona, Laura Mosca, Serena Matis, Marta Lionetti, Sonia Fabris, Luca Agnelli, Monica Colombo, Carlotta Massucco, Manuela Ferracin, Barbara Zagatti, Daniele Reverberi, Massimo Gentile, Anna Grazia Recchia, Sabrina Bossio, Davide Rossi, Gianluca Gaidano, Stefano Molica, Agostino Cortelezzi, Francesco Di Raimondo, Massimo Negrini, Pierfrancesco Tassone, Fortunato Morabito, Manlio Ferrarini & Antonino Neri
Pages: 3150-3158
Published online: 18 May 2015
AbstractforAssociation between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemia | Full Text | References | PDF (544 KB) | Supplemental
  • 490 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis
Yongbin Ye, Xiaojun Xu, Mingwan Zhang, Dafa Qiu, Xiaochun Bai, Jing Wang, Guangyang Weng, Ruiqing Zhou, Ziwen Guo, Huiqing He, Wenfang Yi, Xin He & Kunyuan Guo
Pages: 3159-3167
Published online: 19 Jun 2015
AbstractforLow-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis | Full Text | References | PDF (578.5 KB) | Supplemental
  • 187 Views
  • 6 CrossRef citations
  • 0Altmetric
Article
Anti-leukemic activities of alcoholic extracts of two traditional Indian medicinal plants
Shipra Bhargava, Hemant Malhotra, Om Singh Rathore, Bharti Malhotra, Pratibha Sharma, Amla Batra, Asha Sharma & Shubhada V. Chiplunkar
Pages: 3168-3182
Published online: 12 May 2015
AbstractforAnti-leukemic activities of alcoholic extracts of two traditional Indian medicinal plants | Full Text | References | PDF (777.3 KB) | Supplemental
  • 159 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Fluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes
Judit Sánchez-Castro, Víctor Marco-Betés, Xavier Gómez-Arbonés, Tomás García-Cerecedo, Ricard López, Elisabeth Talavera, Sara Fernández-Ruiz, Vera Ademà, Isabel Marugan, Elisa Luño, Carmen Sanzo, Teresa Vallespí, Leonor Arenillas, Josefa Marco Buades, Ana Batlle, Ismael Buño, María Luisa Martín Ramos, Beatriz Blázquez Rios, Rosa Collado Nieto, Ma Teresa Vargas, Teresa González Martínez, Guillermo Sanz, Francesc Solé & for the Spanish Group for Mds Study (GESMD) and the Spanish Group for Clinical Cytogenetics (Gcecgh)
Pages: 3183-3188
Published online: 12 May 2015
AbstractforFluorescence in situ hybridization of TP53 for the detection of chromosome 17 abnormalities in myelodysplastic syndromes | Full Text | References | PDF (229.8 KB) | Supplemental
  • 462 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Cytomegalovirus induces apoptosis in acute leukemia cells as a virus-versus-leukemia function
Michael Koldehoff, Monika Lindemann, Bertram Opalka, Sebastian Bauer, Rudolf Stefan Ross & Ahmet H. Elmaagacli
Pages: 3189-3197
Published online: 15 May 2015
AbstractforCytomegalovirus induces apoptosis in acute leukemia cells as a virus-versus-leukemia function | Full Text | References | PDF (558 KB) | Supplemental
  • 306 Views
  • 20 CrossRef citations
  • 0Altmetric
Article
NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines
Jan Verner, Martin Trbusek, Jana Chovancova, Zuzana Jaskova, Mojmir Moulis, Frantisek Folber, Roman Halouzka, Jiri Mayer, Sarka Pospisilova & Michael Doubek
Pages: 3198-3206
Published online: 12 May 2015
AbstractforNOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell lines | Full Text | References | PDF (935.3 KB) | Supplemental
  • 832 Views
  • 5 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Persistent major molecular response to nilotinib therapy in a patient with chronic myeloid leukemia harboring ABL gene T315I mutation
Jinyi Zhou, Qi Qu, Suning Chen, Yang Xu, Hongjie Shen, Jiannong Cen & Depei Wu
Pages: 3207-3209
Published online: 26 Aug 2015
First Page PreviewforPersistent major molecular response to nilotinib therapy in a patient with chronic myeloid leukemia harboring ABL gene T315I mutation | Full Text | References | PDF (258.5 KB) | Supplemental
  • 127 Views
  • 1 CrossRef citations
  • 0Altmetric
Letter
Eradication of acquired hemophilia associated with indolent non-Hodgkin lymphoma by a disease specific treatment
Jacopo Mariotti, Giovanni Locatelli, Sonia Cirrincione, Enrica Agostinelli, Daniela Corti, Anna Maggioni, Anna Falanga & Alberto Rosti
Pages: 3210-3212
Published online: 26 Mar 2015
First Page PreviewforEradication of acquired hemophilia associated with indolent non-Hodgkin lymphoma by a disease specific treatment | Full Text | References | PDF (192.4 KB) | Supplemental
  • 118 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
B-cell lymphoma with pseudopapillary features, myxoid changes and lack of CD20 expression: a diagnostic pitfall
Patricia Raciti, Ashleigh Allen, Gregory Mears, Govind Bhagat & Bachir Alobeid
Pages: 3213-3215
Published online: 31 Mar 2015
First Page PreviewforB-cell lymphoma with pseudopapillary features, myxoid changes and lack of CD20 expression: a diagnostic pitfall | Full Text | References | PDF (338.1 KB)
  • 92 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Sustained CD4 and CD8 lymphopenia after rituximab maintenance therapy following bendamustine and rituximab combination therapy for lymphoma
Tsutsumi Yutaka, Shinichi Ito, Hiroyuki Ohigashi, Miyashita Naohiro, Joji Shimono, Shiratori Souichi & Takanori Teshima
Pages: 3216-3218
Published online: 12 May 2015
First Page PreviewforSustained CD4 and CD8 lymphopenia after rituximab maintenance therapy following bendamustine and rituximab combination therapy for lymphoma | Full Text | References | PDF (224 KB) | Supplemental
  • 864 Views
  • 30 CrossRef citations
  • 0Altmetric
Letter
Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia
Line Nederby, Anne S. Roug, Signe S. Knudsen, Anni Skovbo, Eigil Kjeldsen, Holger J. Moller & Marianne Hokland
Pages: 3219-3221
Published online: 28 Mar 2015
First Page PreviewforSoluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia | Full Text | References | PDF (236.9 KB) | Supplemental
  • 281 Views
  • 10 CrossRef citations
  • 0Altmetric
Letter
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
Fabio Forghieri, Ambra Paolini, Monica Morselli, Sara Bigliardi, Goretta Bonacorsi, Giovanna Leonardi, Valeria Coluccio, Monica Maccaferri, Valeria Fantuzzi, Laura Faglioni, Elisabetta Colaci, Francesco Soci, Vincenzo Nasillo, Andrea Messerotti, Laura Arletti, Valeria Pioli, Patrizia Zucchini, Chiara Quadrelli, Giorgia Corradini, Francesca Giacobbi, Daniela Vallerini, Giovanni Riva, Patrizia Barozzi, Ivana Lagreca, Roberto Marasca, Franco Narni, Cristina Mecucci, Emanuela Ottaviani, Giovanni Martinelli, Brunangelo Falini, Mario Luppi & Leonardo Potenza
Pages: 3222-3226
Published online: 12 May 2015
First Page PreviewforNPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms | Full Text | References | PDF (382 KB) | Supplemental
  • 609 Views
  • 20 CrossRef citations
  • 0Altmetric
Letter
Everolimus maintenance in patients with mantle cell lymphoma not eligible for intensive therapy: results of a prematurely closed phase 2 study
Susanne Schreiber, Alexander Hoellein, Thomas Decker, Stefanie Jilg, Martin Dreyling, Christian Peschel & Ulrich Keller
Pages: 3227-3229
Published online: 31 Mar 2015
First Page PreviewforEverolimus maintenance in patients with mantle cell lymphoma not eligible for intensive therapy: results of a prematurely closed phase 2 study | Full Text | References | PDF (216.8 KB) | Supplemental
  • 196 Views
  • 6 CrossRef citations
  • 0Altmetric
Letter
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) with concurrent high grade component at diagnosis: clinico-pathologic features and treatment strategy
Sotirios Sachanas, Gerassimos A. Pangalis, Christina Kalpadakis, Georgia Levidou, Xanthi Yiakoumis, Maria Moschogiannis, Marie-Christine Kyrtsonis, Theodoros P. Vassilakopoulos, Pantelis Tsirkinidis, Marina Siakantaris, Chariklia Spiliadi, Evangelia Karagianni, Penelope Korkolopoulou, Dimitra Rontogianni, Helen Papadaki, Panayiotis Panayiotidis & Maria Angelopoulou
Pages: 3230-3232
Published online: 12 May 2015
First Page PreviewforExtranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT) with concurrent high grade component at diagnosis: clinico-pathologic features and treatment strategy | Full Text | References | PDF (230.3 KB) | Supplemental
  • 108 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
Complete remission of Waldenström's associated generalized crystal-storing histiocytosis of IgM lambda subtype with bortezomib-based combination chemotherapy
Samantha M. Baird, Melita K. Kenealy & Ryan Hoy
Pages: 3233-3235
Published online: 12 May 2015
First Page PreviewforComplete remission of Waldenström's associated generalized crystal-storing histiocytosis of IgM lambda subtype with bortezomib-based combination chemotherapy | Full Text | References | PDF (283.4 KB) | Supplemental
  • 146 Views
  • 4 CrossRef citations
  • 0Altmetric
Letter
Outcomes of acute myeloid leukemia with t(15;17) not associated with acute promyelocytic leukemia
Amy Soni, Miroslav Djokic, Jing-Zhou Hou, Robert L. Redner & Michael Boyiadzis
Pages: 3236-3239
Published online: 20 May 2015
First Page PreviewforOutcomes of acute myeloid leukemia with t(15;17) not associated with acute promyelocytic leukemia | Full Text | References | PDF (214.7 KB) | Supplemental
  • 221 Views
  • 2 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Outcomes of patients aged ≥26 years with relapsed or refractory B-cell acute lymphoblastic leukemia in ZUMA-3 and historical trials
Monique C. Minnema et al.
Article | Published online: 24 May 2024
Open Access
Acceleration of non-Hodgkin lymphoma progression during pregnancy in a murine model
Netanel A. Horowitz et al.
Letter to the Editor | Published online: 23 May 2024
Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B, high TCL1A expression, or over- expressed MYC/BCL-2
Yang Liu et al.
Article | Published online: 22 May 2024
Open Access
Immune escape of B-cell lymphoblastic leukemic cells through a lineage switch to acute myeloid leukemia
Karolina Bełdzińska-Gądek et al.
Article | Published online: 22 May 2024
View all latest articles